Abstract
For centuries, cancer has remained the leading cause of death worldwide despite the advancements in chemotherapy and immunotherapy. The challenges of tumor heterogeneity, drug resistance, and systemic toxicity have impeded effective cancer treatment. The rising number of cancer-related deaths has placed significant pressure on healthcare systems and biopharmaceutical companies to develop new therapeutic approaches. Fortunately, recent advancements in nanotherapies have shown promising results in tackling these obstacles and reducing the risk of multidrug resistance. Nanotherapies have emerged as a key player in cancer treatment by enabling targeted delivery of drugs and minimizing the side effects associated with systemic toxicity. By addressing the limitations of current treatment methods, these innovative strategies offer a new frontier in both cancer screening and treatment. In this chapter, we will explore the role of nanotherapies in cancer and their potential to overcome the challenges faced in conventional cancer treatments.